Eva M. Marwali, MD, PhD, Cindy E

Slides:



Advertisements
Similar presentations
Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Advertisements

A Method to Account for Variation in Congenital Heart Surgery Charges
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Marshall L. Jacobs, MD, Jeffrey P. Jacobs, MD, Sara K
A Method to Account for Variation in Congenital Heart Surgery Charges
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Trevor Williams, MD, MPH, Brian C
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial  Sidney Chocron, MD, PhD, Pierre Vandel, MD, PhD,
The Aristotle Comprehensive Complexity Score Predicts Mortality and Morbidity After Congenital Heart Surgery  Mirela Bojan, MD, MS, Sébastien Gerelli,
Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair 
Early Outcomes of Primary Sutureless Repair of the Pulmonary Veins
Surgery for coarctation of the aorta in infants weighing less than 2 kg  Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Rika E. Ohkuma, MD, Todd C. Crawford, MD, Patricia M
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting
Long-Term Survival After Arterial Versus Atrial Switch in d-Transposition of the Great Arteries  Alexander Kiener, MD, MPH, Michael Kelleman, MSPH, Courtney.
Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M
Castigliano M. Bhamidipati, DO, MS, George J
Outcomes of Different Surgical Strategies in the Treatment of Neonates with Aortic Coarctation and Associated Ventricular Septal Defects  Bahaaldin Alsoufi,
Bahaaldin Alsoufi, MD, Sally Cai, PhD, Glen S
Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D
Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G
Habib Jabagi, MD, MS, Diem T
28 Years' Experience With Transatrial-Transpulmonary Repair of Atrioventricular Septal Defect With Tetralogy of Fallot  Gerard J.F. Hoohenkerk, MD, Paul.
Increased Aorto-Mitral Curtain Thickness Independently Predicts Mortality in Patients With Radiation-Associated Cardiac Disease Undergoing Cardiac Surgery 
Short-Term Outcome of Neonates With Congenital Heart Disease and Diaphragmatic Hernia Treated With Extracorporeal Membrane Oxygenation  Umesh Dyamenahalli,
Trevor Williams, MD, MPH, Brian C
Zhenguo Liu, MD, Huiyu Feng, MD, Sai-Ching J
Tomoaki Murakami, MD, PhD, Atsuhito Takeda, MD, PhD 
Right Ventricular Systolic Dysfunction Assessed by Cardiac Magnetic Resonance Is a Strong Predictor of Cardiovascular Death After Coronary Bypass Grafting 
The Relationship Between Hospital Surgical Case Volumes and Mortality Rates in Pediatric Cardiac Surgery: A National Sample, 1988–2005  Karl F. Welke,
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Analysis of Surgical Outcome in Complex Double-Outlet Right Ventricle With Heterotaxy Syndrome or Complete Atrioventricular Canal Defect  Koh Takeuchi,
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Survival status and functional outcome of children who required prolonged intensive care after cardiac surgery  Siva P. Namachivayam, MBBS, MEpi, Yves.
Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach  Christian McNeely, MD, Alan Zajarias,
Incidence and characteristics of heart block after heart surgery in pediatric patients: A multicenter study  Leonardo Liberman, MD, Eric S. Silver, MD,
Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?  Jeremiah G. Allen, MD, Arman.
Fernando Fleischman, MD, Ramsey S. Elsayed, MD, Robbin G
Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A
Radiofrequency Ablation for the Treatment of Pulmonary Metastases
Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality  Edward L. Hannan, PhD, Zaza Samadashvili,
A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma
Management and Outcomes of Heterotaxy Syndrome Associated With Pulmonary Atresia or Pulmonary Stenosis  Vinod A. Sebastian, MD, Javier Brenes, MD, Raghav.
Characteristics of Malignant Pleural Mesothelioma in Women
Russel Hirsch, Catherine L. Dent, Mary K. Wood, Charles B
Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices  Shinichi Fukuhara, MD,
Optimal Timing for Elective Early Primary Repair of Tetralogy of Fallot: Analysis of Intermediate Term Outcomes  Michael E.A. Cunningham, MD, Mary T.
High Flow Rates During Modified Ultrafiltration Decrease Cerebral Blood Flow Velocity and Venous Oxygen Saturation in Infants  Rosendo A. Rodriguez, MD,
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
John W. Brown, MD, Mark Ruzmetov, MD, PhD, Mark H. Hoyer, MD, Mark D
Correction of Tetralogy of Fallot and of Pulmonary Atresia with Ventricular Septal Defect in Adults  Jürgen Hörer, MD, Julia Friebe, MD, Christian Schreiber,
Prioritizing quality improvement in pediatric cardiac surgery
Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction  David A. Cotoni, DO, Robert T. Palac, MD,
Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival  Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,
Interinstitutional Comparison of Risk-Adjusted Mortality and Length of Stay in Congenital Heart Surgery  William M. DeCampli, MD, PhD, Redmond P. Burke,
Effect of Coronary Artery Disease Extent on Contemporary Outcomes of Combined Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery  Zhongmin.
Mitral Repair Versus Replacement for Ischemic Mitral Regurgitation
Raluca Ionescu-Ittu, MS, Andrew S
Total Anomalous Pulmonary Venous Connection: An Analysis of Current Management Strategies in a Single Institution  Camille L. Hancock Friesen, MD, David.
Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant  Ryan R. Davies, MD, Shylah Haldeman,
International Normalized Ratio Self-Management Lowers the Risk of Thromboembolic Events After Prosthetic Heart Valve Replacement  Thomas Eitz, MD, Soren.
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L
Short Operation Time: An Important Element to Reduce Operative Invasiveness in Pediatric Cardiac Surgery  Makoto Ando, MD, Yukihiro Takahashi, MD, Toshio.
Estimating Mortality Risk for Adult Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database  Stephanie.
Prevalence of Noncardiac and Genetic Abnormalities in Neonates Undergoing Cardiac Operations: Analysis of The Society of Thoracic Surgeons Congenital.
Body Mass Index and Outcome After Ventricular Assist Device Placement
Presentation transcript:

Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass  Eva M. Marwali, MD, PhD, Cindy E. Boom, MD, PhD, Novik Budiwardhana, MD, Dicky Fakhri, MD, PhD, Poppy S. Roebiono, MD, Anwar Santoso, MD, PhD, Sudigdo Sastroasmoro, MD, PhD, April Slee, MS, Michael A. Portman, MD  The Annals of Thoracic Surgery  Volume 104, Issue 2, Pages 688-695 (August 2017) DOI: 10.1016/j.athoracsur.2017.01.001 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Flow diagram for patient allocation and analysis. (CPB = cardiopulmonary bypass; ITT = intention-to-treat; mITT = modified intention-to-treat; T3 = triiodothyronine; TTE = time to extubation.) The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Numbers of patients in subgroup (A) aged ≤5 months and (B) >5 months for each cardiac diagnosis. (CAVC = complete atrioventricular canal; CoA = coarctation of the aorta; IAA = interrupted of aortic arch; PAPVC = partial anomalous pulmonary venous connection; PAVC = partial atrioventricular canal; TAPVC = total anomalous pulmonary venous connection; TOF = tetralogy of Fallot; VSD = ventricular septal defect.) The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Serial measurements of blood free triiodothyronine (FT3) levels (placebo vs drug). The arrows indicate the time when the drug was given (beginning at induction of anesthesia and then every 6 hours for a total of 11 doses). Data are shown as the least squares mean and 95% confidence interval (range bars). The normal range for FT3 is 2.5 to 6.8 pg/mL [15]. The p values are from mixed models for repeated measures, adjusted for age category, Aristotle score, and Z score. The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Serial measurements of blood thyroid-stimulating hormone (TSH) levels (placebo vs drug). Data are shown as least squares mean and 95% confidence interval (range bar). The lowest normal level for TSH is 0.85 μIU/mL [15]. The p values are from mixed models for repeated measures, adjusted for age category, Aristotle score, and Z score. The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Kaplan-Meier curve of time to extubation (TTE) in placebo (Pbo) vs drug in (A) modified intention to treat (mITT) population and (B) by age strata. Longer TTE was showed in the 75th percentile of TTE in placebo compared with triiodothyronine. Number and percentage of patients who remained intubated after cross-clamp removal day are shown below panel A. Hazard ratio (HR), 95% confidence interval (CI), and p values were derived from Cox regression models adjusted for age category, Aristotle score, and Z score. The stratified log-rank p value is presented for comparison and does not indicate a statistically significant difference between groups for the entire cohort. The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Supplemental Figure 1 The Annals of Thoracic Surgery 2017 104, 688-695DOI: (10.1016/j.athoracsur.2017.01.001) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions